What is the Sinclair Method, in plain English?
A plain-English look at the Sinclair Method, a clinician-guided naltrexone approach people research when they want to reduce drinking without starting from immediate abstinence.
The Sinclair Method gets described in two ways that cannot both be true: as a miracle cure and as a fringe idea. It is neither. It is a specific, decades-old way of using a medication the FDA already approves for alcohol problems — naltrexone — for people who want to change their drinking without making total abstinence the first requirement. The medication is ordinary. The confusing part is the timing.
What the medication does, and why timing changes everything
Start with the drug on its own. When you drink, your brain releases its own opioid-like signals — the small internal lift that makes a drink feel rewarding. The American Academy of Family Physicians explains that opioid receptors likely carry a lot of that pleasant effect, and naltrexone sits on those receptors and blocks them. With the receptors blocked, a drink lands flatter. SAMHSA puts it plainly: naltrexone reduces cravings and the amount people drink. It is FDA-approved for alcohol dependence, and none of that is unusual or controversial.
Here is where the method diverges. Naltrexone is often prescribed to be taken every day, whether or not you plan to drink. The Sinclair Method flips that: you take it before drinking, so the block is in place at the exact moment a drink would normally deliver its reward. Do that consistently, and something the brain learned starts to come undone. Your brain built the drinking habit by pairing the act with a reward, over and over. Blunt the reward at the moment it would fire, and — the theory goes — the pairing gradually weakens. Researchers call it pharmacological extinction: the same learning that built the habit, run in reverse. That single idea — medication timed to drinking, not to the calendar — is the whole method.
Where it came from
The approach came out of the work of John David Sinclair, an American behavioral scientist who spent most of his career in Finland studying how the brain attaches reward to repeated behavior. He argued that alcohol use disorder behaves, at the brain level, like a learned habit held in place by the brain's own reward signaling — and that if you could interrupt that signal at the right moment, the habit would loosen on its own. He laid out the case for targeted rather than daily dosing in a 2001 review in Alcohol and Alcoholism. Around the same time, Heinala and colleagues published a clinical study in the Journal of Clinical Psychopharmacology testing targeted naltrexone in people who had not first gone through detox, which helped bring the approach attention outside Finland.
What the evidence supports, and where it stops
Two things are worth separating. That naltrexone is a real, well-supported medicine for alcohol problems is not in question: the Agency for Healthcare Research and Quality puts it among the better-supported oral options in its evidence review, and the World Health Organization recognizes opioid-blocking medications like it as a legitimate approach — used alongside counseling or support, not as a standalone fix. That is solid ground.
What the evidence cannot do is tell you, from a page, whether this particular way of using it fits your history, your goal, and your other medications. That is not a gap the research is expected to close; it is the part that belongs to a clinician who can look at your specific situation. The honest version is: the mechanism is real and the medicine is real, and neither fact settles whether the method is right for you.
Most people never get to have that conversation at all. In 2024, an estimated 27.9 million people ages 12 and older in the U.S. had past-year alcohol use disorder — about 9.7% of that age group, per NIAAA. That same year, roughly 2.1 million of them received any alcohol treatment — about 7.6% — and the number who were offered a medication was smaller still. So if you are reading this, you are already doing the uncommon thing.
Isn't this just naltrexone? And how is it different from Antabuse?
This is the question most people actually arrive with, so it is worth answering head-on. Yes — the Sinclair Method uses the same molecule a clinician might prescribe daily. The difference is not the drug but the strategy: daily naltrexone aims to lower craving around the clock; the targeted version links each dose to drinking so the reward specifically un-learns. Both are recognized ways of using the medicine; they suit different goals and different people, which is exactly the kind of fit a prescriber weighs.
It is also easy to confuse with a different drug entirely. Disulfiram — the one sold as Antabuse — is the medicine that makes you feel sick if you drink; it works like a tripwire and is built around not drinking at all. As one peer-reviewed overview lays out, naltrexone does something opposite in spirit: it does not punish a drink, it quietly drains the reward out of one. If someone tells you the Sinclair Method will make you ill when you drink, they are describing a different medication.
Why your doctor may not have raised it
Naltrexone is mainstream; the targeted way of using it is not, at least not in U.S. primary care. Part of that is training — most primary-care clinicians get only a few hours on alcohol use disorder, usually built around an abstinence-first frame that a "keep drinking, but medicated" approach cuts against. Part of it is time; a short visit does not leave room for a protocol that depends on ongoing conversation. And part is cultural inertia, in a country where twelve-step programs are the default reference point and "drinking less" can sound like cheating. None of that makes the approach wrong. It mostly means you may have to be the one to bring it up.
If you want to explore it, a few concrete moves help. Name your goal plainly — cutting down versus stopping points toward different conversations, and the targeted approach is usually discussed for people still drinking. Bring a real number about how much you drink rather than a vague one; a clinician weighing fit needs an honest picture. And know that opioid history matters a great deal here: naltrexone is not compatible with opioid medications and is one of the first things a prescriber will ask about. If you do not already have a clinician who works with this approach, Clero can connect you with a licensed clinician by telehealth to talk through whether a medication like naltrexone — and this way of using it — makes sense for your situation.
One safety note that the method's "keep drinking" framing can obscure: it is designed around continued drinking, not around quitting cold. If you drink heavily every day, stopping suddenly can be dangerous on its own, and that is a separate question to plan with a clinician before anything else.
This is general education, not medical advice or a prescription. If cutting back has ever brought on shaking, confusion, or a seizure, treat that as an emergency and call 911; if you feel unsafe with yourself, call or text 988; and for confidential help finding treatment, SAMHSA's line is 1-800-662-HELP. Any decision about medication belongs with a licensed clinician who knows your history.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.